Zhejiang Jiuzhou Pharm Co Ltd Total Liabilities
Zhejiang Jiuzhou Pharm Co Ltd total liabilities. Based on the latest financial reports, Zhejiang Jiuzhou Pharm Co Ltd (603456) has total liabilities worth CN¥1.68 Billion CNY (≈ $245.37 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Zhejiang Jiuzhou Pharm Co Ltd (603456) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhejiang Jiuzhou Pharm Co Ltd (2008–2025)
Total liabilities of Zhejiang Jiuzhou Pharm Co Ltd from 2008 to 2025. This chart illustrates how Zhejiang Jiuzhou Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Zhejiang Jiuzhou Pharm Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Zhejiang Jiuzhou Pharm Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Jiuzhou Pharm Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lizhong Sitong Light Alloys Group Co Ltd
SHE:300428
|
China | CN¥17.40 Billion |
|
The Navigator Company SA
LS:NVG
|
Portugal | €1.91 Billion |
|
Youngone
KO:111770
|
Korea | ₩1.69 Trillion |
|
Sh Belling
SHG:600171
|
China | CN¥716.14 Million |
|
Nuscale Power Corp
NYSE:SMR
|
USA | $35.54 Million |
|
Boardwalk Real Estate Investment Trust
TO:BEI-UN
|
Canada | CA$3.98 Billion |
|
Tradegate AG Wertpapierhandelsbank
F:T2G
|
Germany | €257.06 Million |
|
Daetwyl I
SW:DAE
|
Switzerland | CHF695.90 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Zhejiang Jiuzhou Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Zhejiang Jiuzhou Pharm Co Ltd (603456) total assets.
Liquidity & Leverage Metrics
Zhejiang Jiuzhou Pharm Co Ltd Total Liabilities Ratios Explained
Zhejiang Jiuzhou Pharm Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Jiuzhou Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Jiuzhou Pharm Co Ltd (2008–2025)
The table below shows the annual total liabilities of Zhejiang Jiuzhou Pharm Co Ltd from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.81 Billion ≈ $265.21 Million |
-28.01% |
| 2024-12-31 | CN¥2.52 Billion ≈ $368.41 Million |
+8.57% |
| 2023-12-31 | CN¥2.32 Billion ≈ $339.33 Million |
-8.77% |
| 2022-12-31 | CN¥2.54 Billion ≈ $371.94 Million |
+3.19% |
| 2021-12-31 | CN¥2.46 Billion ≈ $360.46 Million |
+28.59% |
| 2020-12-31 | CN¥1.92 Billion ≈ $280.32 Million |
+5.73% |
| 2019-12-31 | CN¥1.81 Billion ≈ $265.14 Million |
+243.94% |
| 2018-12-31 | CN¥526.81 Million ≈ $77.09 Million |
+14.08% |
| 2017-12-31 | CN¥461.77 Million ≈ $67.57 Million |
+6.89% |
| 2016-12-31 | CN¥432.01 Million ≈ $63.22 Million |
-47.28% |
| 2015-12-31 | CN¥819.46 Million ≈ $119.91 Million |
+31.12% |
| 2014-12-31 | CN¥624.98 Million ≈ $91.45 Million |
-23.25% |
| 2013-12-31 | CN¥814.26 Million ≈ $119.15 Million |
+9.11% |
| 2012-12-31 | CN¥746.26 Million ≈ $109.20 Million |
+14.28% |
| 2011-12-31 | CN¥653.04 Million ≈ $95.56 Million |
+27.54% |
| 2010-12-31 | CN¥512.03 Million ≈ $74.93 Million |
+31.81% |
| 2009-12-31 | CN¥388.45 Million ≈ $56.84 Million |
-5.55% |
| 2008-12-31 | CN¥411.27 Million ≈ $60.18 Million |
-- |
About Zhejiang Jiuzhou Pharm Co Ltd
Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecules, drug products, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, an… Read more